De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine

BACKGROUND: Entecavir-resistance mutations are commonly induced by entecavir treatment in chronic hepatitis B patients. However, entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations induced by sequential or combination treatment with lamivudine and adefovir dipivoxil have never been r...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Clin Microbiol Antimicrob
Huvudupphovsmän: Yang, Song, Xing, Huichun, Wang, Qi, Wang, Xiaomei, Liu, Shunai, Cheng, Jun
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4832522/
https://ncbi.nlm.nih.gov/pubmed/27079793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-016-0138-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk